IRVINE, Calif.--(BUSINESS WIRE)--Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab that empowers every person by providing access to accurate, clinical testing when and where it matters most, announces today the launch of its Diagnostics as a Service (DaaS) platform, giving brands the ability to provide their patients with access to at-home healthcare at any time and anywhere.
Digital health and healthcare DTC entities - including fertility clinics, OBGYNs, primary care providers and pharmacies - can utilize IHD’s partner platform to offer consumers over 70 different at-home tests, from infectious disease and wellness to women’s and men’s health. The platform bridges the gap between digital health services and diagnostics - creating a more complete customer experience with emphasis on fast turnaround times, actionable results, and superior customer service provided by IHD.
“Our DaaS platform furthers our mission of providing a better experience across medication, treatment and overall understanding of personal health,” said IHD CEO and Co-Founder David White. “By offering at-home testing, digital health and healthcare entities can significantly increase access to wider customer segments, whether it be additional geographies, opening new prescriptions, or extending to new market segments.”
Accelerating at-home testing services for healthcare companies, IHD’s new platform enables a better customer experience and outcomes, seamless technology integration, and custom kits built specifically for the unique mix of tests required by the partner and its patients.
IHD’s health partners can leverage the company’s end-to-end DaaS platform or select individual modules that fit into the brand’s existing operation, such as logistics and clinical networks. IHD serves as a collaborative and flexible partner while maintaining the highest standards of testing methodologies, quick turnaround times and affordability.
About Innovative Health Diagnostics
Innovative Health Diagnostics (IHD) empowers every person by providing access to accurate, clinical testing, when and where it matters most. IHD services also include fertility and in vitro fertilization (IVF) testing; FDA donor testing for families completing surrogacies; and COVID-19 polymerase chain reaction (PCR) and antibody testing.
A nimble, collaborative partner, IHD operates with the patient in mind at all times, offering the highest standards of integrity and service, quick turnaround times, and affordability. To learn more, please visit ihdlab.com or follow us on LinkedIn, Twitter, Facebook and Instagram.
